Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Drug-maker Wockhardt has appointed a United States-based consultant to help wade through quality issues at one of its Waluj plants, as pointed out by the US Food and Drug Administration. As details of the company’s quality transgressions become public, Wockhardt sought to allay intense market speculation that the shadow cast by the FDA warning could in spread to other plants too. In a recent letter, Wockhardt’s Murtaza Khorakiwala, said that the consultant had extensive experience and expertise in good manufacturing practice norms and they would work with the company to address issues raised by the USFDA.
Help employers find you! Check out all the jobs and post your resume.
Drug-maker Wockhardt has appointed a United States-based consultant to help wade through quality issues at one of its Waluj plants, as pointed out by the US Food and Drug Administration. As details of the company’s quality transgressions become public, Wockhardt sought to allay intense market speculation that the shadow cast by the FDA warning could in spread to other plants too. In a recent letter, Wockhardt’s Murtaza Khorakiwala, said that the consultant had extensive experience and expertise in good manufacturing practice norms and they would work with the company to address issues raised by the USFDA.
Help employers find you! Check out all the jobs and post your resume.
